CSTL Castle Bio: Year-over-year earnings per share growth for the last twelve months

Graphic logo of Castle Biosciences (CSTL)

Quarterly EPS growth demonstrates the resilience of Castle Biosciences (CSTL), whose position is strengthened by patents and Medicare trust. Process robotization utilizing AI minimizes gene analysis errors, while high-demand dermatology tests reduce the number of unnecessary surgical interventions. Meanwhile, -674.80 serves as the current parameter value, allowing the market to filter out noise and assess the real dynamics of earnings per share.

CSTL: Castle Biosciences, Inc. Earnings per share growth in annualized terms for the last twelve months 07/04/2022 - 11/13/2026

Summary analytical data breakdowns for Castle Bio (CSTL)

- share price and expert price forecast:
Stock Price Castle Biosciences, Inc.|CSTL - Analyst Consensus Forecast
- company stock capitalization data:
Market Value Castle Biosciences Corp|CSTL - Total Company Value
- book capitalization data:
Accounting Value per Share Castle Biosciences|CSTL - Total Stockholders' Equity|Market Value to Book Value Ratio castlebiosciences.com|CSTL - Company Total Asset Base
- debt burden and liquidity indicators:
Total Debt to Capital Castle Biosciences|CSTL - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Castle Biosciences|CSTL - Company Total Debt Obligations|Debts to Book Capitalization Castle Biosciences Corp|CSTL - Company Long-Term Liabilities|Company Short-Term Debts Castle Biosciences|Quick Liquidity castlebiosciences.com
- earnings and valuation multiples information:
CSTL - Net Financial Result|Future Profit Castle Biosciences|CSTL - Market Price to Net Income Ratio|Future Price to Earnings Castle Biosciences Corp|CSTL - Price/Earnings to Growth Ratio|EV/EBITDA Multiple Castle Biosciences Corp|CSTL - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Castle Biosciences|CSTL - Earnings per share for the trailing year|Quarterly EPS earnings growth castlebiosciences.com|CSTL - Earnings per share growth in current year|Earnings growth forecast for next year Castle Biosciences
Analysis of all company metrics:Castle Biosciences, Inc. - CSTL
Flagship merchandise of Castle Biosciences

Castle Biosciences' resilience to market shocks is driven by the stability of its cash flows. The implementation of molecular tests in oncodermatology creates inertial demand, ensuring predictable revenue. The quarter-over-quarter EPS dynamics measure the rate of change in net income per share relative to the previous period. Growth in this metric confirms the effectiveness of the business scaling. It is critical for investors to compare current values with the historical trend to assess overbought risks.

Main competitors

CAI: Quarterly EPS earnings growth|Guardant Health Inc (GH) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Veracyte Corp|Year-over-year earnings per share growth for the last twelve months CELC|Year-over-year net earnings per share growth for the last 12 months GRAL (GRAIL, Inc.)|MYGN - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Burning Rock BNR|Year-over-year net earnings per share change for the last twelve months VolitionRx Ltd. (VNRX)|Biodesix Corp - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Precipio Inc PRPO|check-cap.com (CHEK) - Year-over-year earnings per share growth for the last twelve months|MYNZ - Year-over-year net earnings per share change for the last twelve months|OCX (OncoCyte) - Quarterly EPS earnings growth